Tiffany L Breger1, Daniel Westreich2, Andrew Edmonds2, Jessie K Edwards2, Lauren C Zalla2, Stephen R Cole2, Catalina Ramirez1, Igho Ofotokun3, Seble G Kassaye4, Todd T Brown5, Deborah Konkle-Parker6, Deborah L Jones7, Gypsyamber D'Souza8, Mardge H Cohen9, Phyllis C Tien10, Tonya N Taylor11, Kathryn Anastos12, Adaora A Adimora1,2. 1. Department of Medicine, University of North Carolina School of Medicine,Chapel Hill. 2. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, at Chapel Hill, North Carolina. 3. Department of Medicine, Emory University School of Medicine, Atlanta, Georgia. 4. Department of Medicine, Georgetown University, Washington, District of Columbia. 5. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland. 6. Department of Medicine, School of Nursing, University of Mississippi, Jackson, MS. 7. Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida. 8. Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. 9. Department of Medicine, Stroger Hospital of Cook County Health and Hospitals System, Chicago, Illinois. 10. Department of Medicine, University of California San Francisco, and Department of Veterans Affairs, San Francisco, California. 11. Department of Medicine, SUNY Downstate Health Sciences University, Brooklyn. 12. Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
Abstract
OBJECTIVES: The aim of this study was to define a smoking cessation 'cascade' among USA women with and without HIV and examine differences by sociodemographic characteristics. DESIGN: An observational cohort study using data from smokers participating in the Women's Interagency HIV Study between 2014 and 2019. METHODS: We followed 1165 women smokers with and without HIV from their first study visit in 2014 or 2015 until an attempt to quit smoking within approximately 3 years of follow-up, initial cessation (i.e. no restarting smoking within approximately 6 months of a quit attempt), and sustained cessation (i.e. no restarting smoking within approximately 12 months of a quit attempt). Using the Aalen-Johansen estimator, we estimated the cumulative probability of achieving each step, accounting for the competing risk of death. RESULTS: Forty-five percent of smokers attempted to quit, 27% achieved initial cessation, and 14% achieved sustained cessation with no differences by HIV status. Women with some post-high school education were more likely to achieve each step than those with less education. Outcomes did not differ by race. Thirty-six percent [95% confidence interval (95% CI): 31-42] of uninsured women attempted to quit compared with 47% (95% CI: 44-50) with Medicaid and 49% (95% CI: 41-59) with private insurance. CONCLUSION: To decrease smoking among USA women with and without HIV, targeted, multistage interventions, and increased insurance coverage are needed to address shortfalls along this cascade.
OBJECTIVES: The aim of this study was to define a smoking cessation 'cascade' among USA women with and without HIV and examine differences by sociodemographic characteristics. DESIGN: An observational cohort study using data from smokers participating in the Women's Interagency HIV Study between 2014 and 2019. METHODS: We followed 1165 women smokers with and without HIV from their first study visit in 2014 or 2015 until an attempt to quit smoking within approximately 3 years of follow-up, initial cessation (i.e. no restarting smoking within approximately 6 months of a quit attempt), and sustained cessation (i.e. no restarting smoking within approximately 12 months of a quit attempt). Using the Aalen-Johansen estimator, we estimated the cumulative probability of achieving each step, accounting for the competing risk of death. RESULTS: Forty-five percent of smokers attempted to quit, 27% achieved initial cessation, and 14% achieved sustained cessation with no differences by HIV status. Women with some post-high school education were more likely to achieve each step than those with less education. Outcomes did not differ by race. Thirty-six percent [95% confidence interval (95% CI): 31-42] of uninsured women attempted to quit compared with 47% (95% CI: 44-50) with Medicaid and 49% (95% CI: 41-59) with private insurance. CONCLUSION: To decrease smoking among USA women with and without HIV, targeted, multistage interventions, and increased insurance coverage are needed to address shortfalls along this cascade.
Authors: Karen L Cropsey; James H Willig; Michael J Mugavero; Heidi M Crane; Cheryl McCullumsmith; Sarah Lawrence; James L Raper; W Christopher Mathews; Stephen Boswell; Mari M Kitahata; Joseph E Schumacher; Michael S Saag Journal: J Addict Med Date: 2016 Jan-Feb Impact factor: 3.702
Authors: Christina Ludema; Stephen R Cole; Joseph J Eron; G Mark Holmes; Kathryn Anastos; Jennifer Cocohoba; Marge H Cohen; Hannah L F Cooper; Elizabeth T Golub; Seble Kassaye; Deborah Konkle-Parker; Lisa Metsch; Joel Milam; Tracey E Wilson; Adaora A Adimora Journal: Am J Hypertens Date: 2017-06-01 Impact factor: 2.689
Authors: Gypsyamber D'Souza; Fiona Bhondoekhan; Lorie Benning; Joseph B Margolick; Adebola A Adedimeji; Adaora A Adimora; Maria L Alcaide; Mardge H Cohen; Roger Detels; M Reuel Friedman; Susan Holman; Deborah J Konkle-Parker; Daniel Merenstein; Igho Ofotokun; Frank Palella; Sean Altekruse; Todd T Brown; Phyllis C Tien Journal: Am J Epidemiol Date: 2021-08-01 Impact factor: 5.363
Authors: Daniel Westreich; Jordan Cates; Mardge Cohen; Kathleen M Weber; Dominika Seidman; Karen Cropsey; Rodney Wright; Joel Milam; Mary A Young; C Christina Mehta; Deborah R Gustafson; Elizabeth T Golub; Margaret A Fischl; Adaora A Adimora Journal: AIDS Date: 2017-02-20 Impact factor: 4.177
Authors: Maya Vijayaraghavan; Patrick Yuan; Steven Gregorich; Paula Lum; Nicole Appelle; Anna Maria Napoles; Sara Kalkhoran; Jason Satterfield Journal: Prev Med Rep Date: 2017-02-21
Authors: Tiffany L Breger; Jessie K Edwards; Stephen R Cole; Michael Saag; Peter F Rebeiro; Richard D Moore; Joseph J Eron Journal: Epidemiology Date: 2020-09 Impact factor: 4.860